Retina

SEATTLE — A laboratory study showed significant variation in accuracy and residual volume among syringes commonly used for intravitreal injections and evaluated the risk for high IOP elevation with higher than anticipated fluid volumes.

SEATTLE — A study based on IRIS Registry data delved into the rates, risk factors, management strategies and outcomes of post-intravitreal anti-VEGF injection endophthalmitis.

Healio’s recent coverage of the American Society of Retina Specialists annual meeting included a study about the burden of geographic atrophy and updates on Syfovre inflammation reports.

SEATTLE — Initial experience with two ranibizumab biosimilars showed no unexpected adverse events, according to a study presented at the American Society of Retina Specialists annual meeting.

HG004, a gene replacement therapy, received rare pediatric disease designation from the FDA for the treatment of inherited retinal diseases caused by RPE65 mutations, according to a press release from HuidaGene.

The FDA approved Izervay, a complement C5 inhibitor, for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Astellas Pharma.

SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Allen C. Ho, MD, FASRS, discusses 6-month data on MCO-010 optogenetic therapy in patients with Stargardt disease.

SEATTLE — In this Healio Video Perspective from the ASRS annual meeting, Nassim Abreu-Arbaje, MD, discusses his positive experience using Norlase laser technology for retina surgery.

SEATTLE — Home OCT provides an unprecedented view of fluid recurrence and resolution patterns in individual patients, allowing for prompt, personalized treatment.

SEATTLE — The effects of aflibercept treatment in the three arms of the PULSAR study were not affected by baseline characteristics, according to four subgroup analyses presented at the American Society of Retina Specialists annual meeting.